High-dose chemotherapy with autologous stem cell support does not improve outcome in the first-line treatment of aggressive non-Hodgkin lymphoma - Results of a comprehensive meta-analysis

被引:0
作者
Greb, A
Bohlius, J
Schwarzer, G
Schiefer, D
Engert, A
机构
[1] German Cochrane Ctr, Inst Med Biometry & Med Informat, Freiburg, Germany
[2] Univ Cologne, Dept Internal Med 1, Cochrane Haematol Malignancies Grp, Cologne, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
068
引用
收藏
页码:55 / 55
页数:1
相关论文
共 50 条
  • [31] High-dose chemotherapy with tandem autologous transplantation as part of the initial therapy for aggressive non-Hodgkin's lymphoma
    Ballestrero, A
    Clavio, M
    Ferrando, F
    Gonella, R
    Garuti, A
    Sessarego, M
    Ghio, R
    Gobbi, M
    Patrone, F
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2000, 17 (05) : 1007 - 1013
  • [32] HIGH-DOSE CARBOPLATIN, ETOPOSIDE AND IFOSFAMIDE AND AUTOLOGOUS STEM-CELL RESCUE IN THE TREATMENT OF NON-HODGKIN LYMPHOMA
    SIEGERT, W
    PATHOLOGIE BIOLOGIE, 1993, 41 (01): : 104 - 104
  • [33] BEAM OR BUCYE HIGH-DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION IN NON-HODGKIN'S LYMPHOMA PATIENTS
    Suh, C.
    Kim, J. E.
    Sohn, B. S.
    Yoon, D. H.
    Lee, D. H.
    Kim, S. W.
    Lee, J. S.
    Kim, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 643 - 643
  • [34] High-dose chemotherapy and autologous stem cell transplantation as first-line treatment without consolidating radiotherapy for primary CNS lymphoma
    Illerhaus, G.
    Mueller, F.
    Marks, R.
    Ostertag, C.
    Finke, J.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S148 - S148
  • [35] Autologous Hematopoietic Stem Cell Transplantation Combined with High-Dose Chemotherapy As First-Line Treatment for HIV-Associated Lymphoma: A Retrospective Analysis
    Guo, Bingling
    Hu, Renzhi
    Liang, Xiping
    Yang, Zailin
    Yang, Tao
    Wang, Chaoyu
    Hu, Chongling
    Zhang, Wenjun
    Xiao, Chunyan
    Liu, Jun
    Huang, Dehong
    Liu, Tingting
    Nan, Yingyu
    Li, Jieping
    Liu, Yao
    BLOOD, 2023, 142
  • [36] BEAM or BuCyE high-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma patients
    Kim, J.
    Kim, E.
    Sohn, B.
    Yoon, D.
    Yoo, C.
    Kim, S.
    Lee, D.
    Kim, S.
    Lee, J.
    Suh, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [37] High-dose chemoradiotherapy and autologous stem cell transplantation for patients with primary refractory aggressive non-Hodgkin lymphoma: an intention-to-treat analysis
    Kewalramani, T
    Zelenetz, AD
    Hedrick, EE
    Donnelly, GB
    Hunte, S
    Priovolos, AC
    Qin, J
    Lyons, NC
    Yahalom, J
    Nimer, SD
    Moskowitz, CH
    BLOOD, 2000, 96 (07) : 2399 - 2404
  • [38] Treatment of multicentric Castleman's disease complicated by the development of non-Hodgkin's lymphoma with high-dose chemotherapy and autologous peripheral stem-cell support
    Advani, R
    Warnke, R
    Rosenberg, S
    ANNALS OF ONCOLOGY, 1999, 10 (10) : 1207 - 1209
  • [39] Upfront double high-dose chemotherapy with DICEP followed by BEAM and autologous stem cell transplantation for poor-prognosis aggressive non-Hodgkin lymphoma
    Stewart, Douglas A.
    Bahlis, Nizar
    Valentine, Karen
    Balogh, Alex
    Savoie, Lynn
    Morris, Donald G.
    Jones, Allan
    Brown, Chris
    Russell, James A.
    BLOOD, 2006, 107 (12) : 4623 - 4627
  • [40] High-Dose Chemotherapy Followed by Autologous Stem Cell Transplantation as a First-Line Therapy for High-Risk Primary Breast Cancer: A Meta-Analysis
    Wang, Jing
    Zhang, Qiguo
    Zhou, Rongfu
    Chen, Bing
    Ouyang, Jian
    PLOS ONE, 2012, 7 (03):